Accuray Incorporated (ARAY) Stock Price

ARAYStock

$0.27−82.92%52W

Market Cap$31.78M

P/E—

PEG Ratio29.49

Div yield—

Beta1.45

ARAY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-60.00%

Price vs S&P 500 (4W)8.53%

PEG Ratio29.49

VGM Score43.01

P/CF (Annual)11.50x

Book Value / Share (Quarterly)$0.35

P/TBV (Annual)2.15x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)2.17%

Cash Flow / Share (Quarterly)$-0.22

Price vs S&P 500 (YTD)-78.84%

Gross Margin (TTM)26.90%

Net Profit Margin (TTM)-10.76%

EPS (TTM)$-0.38

10-Day Avg Trading Volume0.79M

EPS Excl Extra (TTM)$-0.38

Revenue Growth (5Y)3.67%

EPS (Annual)$-0.02

ROI (Annual)-0.73%

Gross Margin (Annual)32.05%

Net Profit Margin (5Y Avg)-1.75%

Cash / Share (Quarterly)$0.32

Revenue Growth QoQ (YoY)-7.42%

ROA (Last FY)-0.34%

Revenue Growth TTM (YoY)-7.88%

EBITD / Share (TTM)$-0.16

ROE (5Y Avg)-14.58%

Operating Margin (TTM)-6.13%

Cash Flow / Share (Annual)$-0.01

P/B Ratio0.79x

P/B Ratio (Quarterly)1.11x

Net Income / Employee (Annual)$-1,600

EV / Revenue (TTM)0.33x

Net Interest Coverage (TTM)1.15x

ROA (TTM)-10.12%

EV / EBITDA (TTM)21.50x

EPS Incl Extra (Annual)$-0.02

Current Ratio (Annual)1.65x

Quick Ratio (Quarterly)0.61x

3-Month Avg Trading Volume2.73M

52-Week Price Return-82.92%

Revenue / Employee (TTM)$432,900

Tangible BV / Share (Quarterly)$0.21

P/S Ratio (Annual)0.07x

Asset Turnover (Annual)0.97x

52-Week High$2.10

Operating Margin (5Y Avg)1.53%

EPS Excl Extra (Annual)$-0.02

CapEx CAGR (5Y)2.75%

Tangible BV CAGR (5Y)0.83%

26-Week Price Return-48.75%

Quick Ratio (Annual)0.85x

13-Week Price Return-12.39%

Total Debt / Equity (Annual)1.68x

Current Ratio (Quarterly)1.42x

Enterprise Value$140.02M

Revenue / Share Growth (5Y)1.09%

Asset Turnover (TTM)0.94x

Book Value / Share Growth (5Y)0.66%

Revenue / Employee (Annual)$463,100

Inventory Turnover (Annual)2.23x

Pretax Margin (Annual)0.25%

Cash / Share (Annual)$0.51

3-Month Return Std Dev112.80%

Gross Margin (5Y Avg)35.20%

Net Income / Employee (TTM)$-46,600

EBITDA CAGR (5Y)-5.05%

ROE (Last FY)-1.96%

Net Interest Coverage (Annual)-1.55x

EPS Basic Excl Extra (Annual)$-0.02

P/FCF (TTM)1.16x

Receivables Turnover (TTM)5.85x

EV / Free Cash Flow (TTM)9.50x

Total Debt / Equity (Quarterly)3.48x

EPS Incl Extra (TTM)$-0.38

Receivables Turnover (Annual)5.18x

ROI (TTM)-23.18%

P/S Ratio (TTM)0.08x

Pretax Margin (5Y Avg)-1.11%

Revenue / Share (Annual)$4.46

Tangible BV / Share (Annual)$0.58

Price vs S&P 500 (52W)-101.23%

Year-to-Date Return-66.88%

5-Day Price Return-13.78%

EPS Normalized (Annual)$-0.02

ROA (5Y Avg)-1.61%

Net Profit Margin (Annual)-0.35%

Month-to-Date Return1.31%

Cash Flow / Share (TTM)$-0.02

EBITD / Share (Annual)$0.15

Operating Margin (Annual)2.03%

LT Debt / Equity (Annual)1.52x

P/CF (TTM)8.95x

ROI (5Y Avg)-3.36%

LT Debt / Equity (Quarterly)3.21x

EPS Basic Excl Extra (TTM)$-0.38

P/TBV (Quarterly)1.87x

P/B Ratio (Annual)1.74x

Inventory Turnover (TTM)2.07x

Pretax Margin (TTM)-10.19%

Book Value / Share (Annual)$0.72

Price vs S&P 500 (13W)-15.18%

Beta1.45x

P/FCF (Annual)11.50x

Revenue / Share (TTM)$3.45

ROE (TTM)-77.48%

52-Week Low$0.22

vGradeA

gGradeD

mGradeF

vgmGradeC

ARAY Earnings Surprise History

Q2 250.01est. 0.01

Q3 25-0.14est. -0.05

Q4 25-0.11est. -0.11

Q1 26-0.07est. -0.05

Q2 260.00est. —

ARAY Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.38

2.29

2.17

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
ARAYAccuray Incorporated	A	D	F	$0.27
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Accuray Incorporated

Accuray manufactures the CyberKnife, a precision radiation oncology system for treating cancers and tumors throughout the body. The system automatically detects and corrects for tumor and patient movement in real-time, delivering high-dose radiation with sub-millimeter accuracy while patients breathe normally and without requiring manual intervention. This technology sets the standard for precision radiation therapy in cancer treatment.